Abstract

Acute respiratory failure and ARDS remains an important cause of mortality and morbidity in patients admitted to the ICU. Several trials were conducted to improve the survival in patients with respiratory failure. The efficacy and safety of the use of surfactant in improving the outcomes of patients with ARDS was recently evaluated in several trials.